serds for patients with er /her2- breast cancer
Published 1 year ago • 571 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
2:35
what does the future hold for serds in er breast cancer?
-
1:17
key trial updates in serds in er /her2- breast cancer from sabcs 2022
-
1:51
ameera-3: serd for er her2- breast cancer
-
1:00
utilizing neoadjuvant immunotherapies in patients with er , her2- primary breast cancer
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
4:40
ameera-1 updates: amcenestrant plus palbociclib for patients with er /her2– advanced breast cancer
-
1:05
cambria 1: camizestrant er /her2- early breast cancer
-
2:03
emerald: elacestrant vs. soc for patients with er her2- metastatic breast cancer
-
0:51
ember-2: preoperative imlunestrant for er /her2- early stage breast cancer
-
1:02:48
expanding treatment options in er /her2- breast cancer: serds, serms, sercas, and more
-
5:37
therapeutic landscape for patients with her2-positive breast cancer with active brain metastases
-
1:01
future of breast cancer care: her2 therapies in earlier settings & de-escalation
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
0:52
first-line camizestrant for er /her2- advanced breast cancer
-
2:46
ameera-3: amcenestrant does not improve pfs in er /her2- breast cancer
-
1:27
emerald: elacestrant vs physicians choice in er /her2- breast cancer
-
4:37
predict underestimates survival of patients with her2 early breast cancer
-
4:06
serena-2: camizestrant vs fulvestrant in post-menopausal women with advanced er /her- breast cancer